[continued from previous message]

Regulation of TREM2 expression by an NF-кB-sensitive miRNA-34a.
[Neuroreport. 2013]
Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
[Neurobiol Aging. 2014]
Regulating amyloidogenesis through the natural triggering receptor expressed in myeloid/microglial cells 2 (TREM2).
[Front Cell Neurosci. 2014]
Alzheimer's disease and the microbiome.
[Front Cell Neurosci. 2013]
Pathogenic microbes, the microbiome, and Alzheimer's disease (AD).
[Front Aging Neurosci. 2014]
Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
[Biomed J. 2014]
Review The human intestinal microbiome: a new frontier of human biology.
[DNA Res. 2009]
Review Microbial amyloids--functions and interactions within the host.
[Curr Opin Microbiol. 2013]
Review Fold modulating function: bacterial toxins to functional amyloids. [Front Microbiol. 2014]
Alzheimer's disease and disseminated mycoses.
[Eur J Clin Microbiol Infect Dis. 2014]
Fungal infection in patients with Alzheimer's disease.
[J Alzheimers Dis. 2014]
Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?
[J Alzheimers Dis. 2014]
Bacterial amyloids.
[Methods Mol Biol. 2012]
Review Blood-brain-barriers in aging and in Alzheimer's disease.
[Mol Neurodegener. 2013]
Review Vascular hyperpermeability and aging.
[Aging Dis. 2014]
Review Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
[Neurodegener Dis. 2007]
Review Amyloid precursor protein processing and Alzheimer's disease.
[Annu Rev Neurosci. 2011]
Review Proteolytic processing of Alzheimer's β-amyloid precursor protein.
[J Neurochem. 2012]
Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease.
[Neuroreport. 2011]
Review The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.
[Cell Adh Migr. 2011]
Ribonuclease A suggests how proteins self-chaperone against amyloid fiber formation.
[Protein Sci. 2012]
Review Plaques and tangles and the pathogenesis of Alzheimer's disease.
[Folia Neuropathol. 2006]
Expression of inflammatory genes in the primary visual cortex of late-stage Alzheimer's disease.
[Neuroreport. 2007]
Review The innate immune system in Alzheimer's disease.
[Int J Cell Biol. 2013]
Review Functional diversity of protein fibrillar aggregates from physiology to RNA granules to neurodegenerative diseases.
[Biochim Biophys Acta. 2013]
Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
[Neurobiol Aging. 2014]
Review Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.
[Neuroimmunomodulation. 2014]
Review Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy.
[Front Aging Neurosci. 2014]
Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
[J Neurosci Res. 2002]
Review Amyloids: friend or foe?
[J Alzheimers Dis. 2008]
Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
[Chembiochem. 2011]
Review Diversity, biogenesis and function of microbial amyloids.
[Trends Microbiol. 2012]
Bacterial amyloids.
[Methods Mol Biol. 2012]
"Congo" red: out of Africa?
[Arch Pathol Lab Med. 2001]
Review A molecular history of the amyloidoses.
[J Mol Biol. 2012]
Lipopolysaccharide induced conversion of recombinant prion protein.
[Prion. 2014]
A study on the association between infectious burden and Alzheimer's disease. [Eur J Neurol. 2014]
Review Effect of intestinal microbial ecology on the developing brain.
[JAMA Pediatr. 2013]
Review [Anti-basal ganglia antibody].
[Brain Nerve. 2013]
Review The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness.
[Curr Opin Rheumatol. 2013]
Review Extragastric diseases and Helicobacter pylori.
[Helicobacter. 2013]
Pathogenic microbes, the microbiome, and Alzheimer's disease (AD).
[Front Aging Neurosci. 2014]
A study on the association between infectious burden and Alzheimer's disease. [Eur J Neurol. 2014]
Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2.
[Cell Host Microbe. 2009]
Review Microglia during development and aging.
[Pharmacol Ther. 2013]
Microglial Aβ receptors in Alzheimer's disease.
[Cell Mol Neurobiol. 2015]
Microbial amyloids induce interleukin 17A (IL-17A) and IL-22 responses via Toll-like receptor 2 activation in the intestinal mucosa.
[Infect Immun. 2012]
Alzheimer's disease and the microbiome.
[Front Cell Neurosci. 2013]
Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation?
[J Alzheimers Dis. 2014]
Activation of innate immunity by lysozyme fibrils is critically dependent on cross-β sheet structure.
[Cell Mol Life Sci. 2013]
Th17 cell-mediated neuroinflammation is involved in neurodegeneration of aβ1-42-induced Alzheimer's disease model rats.
[PLoS One. 2013]
Bacterial amyloids.
[Methods Mol Biol. 2012]
Review Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.
[Neuroimmunomodulation. 2014]
Alzheimer's disease and the microbiome.
[Front Cell Neurosci. 2013]
Review Blood-brain-barriers in aging and in Alzheimer's disease.
[Mol Neurodegener. 2013]
Age-associated remodeling of the intestinal epithelial barrier.
[J Gerontol A Biol Sci Med Sci. 2013]
Review Vascular hyperpermeability and aging.
[Aging Dis. 2014]
CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers.
[J Biol Chem. 2013]
Th17 cell-mediated neuroinflammation is involved in neurodegeneration of aβ1-42-induced Alzheimer's disease model rats.
[PLoS One. 2013]
Microglial Aβ receptors in Alzheimer's disease.
[Cell Mol Neurobiol. 2015]
Pathogenic microbes, the microbiome, and Alzheimer's disease (AD).
[Front Aging Neurosci. 2014]
Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
[Biomed J. 2014]
You are here: NCBI > Literature > PubMed Central (PMC)Write to the Help Desk External link. Please review our privacy policy.
NLM NIH DHHS USA.gov
Copyright | Disclaimer | Privacy | Browsers | Accessibility | Contact
National Center for Biotechnology Information, U.S. National Library of Medicine
8600 Rockville Pike, Bethesda MD, 20894 USA




http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322713/

--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)